Reported Reactions

Devices › Radioimmunoassay, total triiodothyronine

Device brand name · Radioimmunoassay total triiodothyronine

Ft3 - Free Triiodothyronine: medical device reports filed with FDA

249 reports name it, 2011–2022. Manufacturer given most often on reports: Roche Diagnostics. Product code CDP.

249
device reports naming the brand
0% of all MAUDE reports · about 17 a year
0
reports, 12 months to August 2026
0 in the 12 months before
100%
classified as malfunction
98.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

249 medical device reports received by FDA name the brand "Ft3 - Free Triiodothyronine" (radioimmunoassay total triiodothyronine); the manufacturer given most often on reports is Roche Diagnostics; received from June 2011 to December 2022. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (100%); across all radioimmunoassay, total triiodothyronine reports (product code CDP) death is recorded in 0% and malfunction in 98.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are high test results (49.4%), incorrect or inadequate test results (36.9%) and low test results (4%). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

023Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 3Apr 2022: 0May 2022: 1Jun 2022: 3Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 12023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0651302011: 420112013: 420132014: 3120142015: 13020152016: 6420162017: 820172022: 82022

Event type and report source

Event type, as classified on the report

Death0%0
Injury0%0
Malfunction100%249
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%249
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 1,979 reports carrying product code CDP. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
High test results12349.4%51.4%
Incorrect or inadequate test results9236.9%13.3%
Low test results104%15.5%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

In context

MeasureFt3 - Free TriiodothyronineProduct code CDPAll MAUDE reports
Reports2491,97926,136,888
Share of that pool—12.6%0%
Classified as death, per 1,000 reports009
Classified as injury0%0.7%36.2%
Classified as malfunction100%98.8%62.3%
Filed by the manufacturer100%99.8%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code CDP

BrandReportsLatest 12 monthsClassified as death
Architect Free T329100%
Architect Total T324100%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Ft3 - Free Triiodothyronine reports

How many FDA reports name Ft3 - Free Triiodothyronine?

249 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

high test results (49.4%), incorrect or inadequate test results (36.9%) and low test results (4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Ft3 - Free Triiodothyronine was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.